You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
The role of bariatric surgery to treat diabetes: current challenges and perspectives
|
|---|---|
| Published in |
BMC Endocrine Disorders, August 2017
|
| DOI | 10.1186/s12902-017-0202-6 |
| Pubmed ID | |
| Authors |
Chrysi Koliaki, Stavros Liatis, Carel W. le Roux, Alexander Kokkinos |
| Abstract |
Bariatric surgery is emerging as a powerful weapon against severe obesity and type 2 diabetes mellitus (T2DM). Given its role in metabolic regulation, the gastrointestinal tract constitutes a meaningful target to treat T2DM, especially in light of accumulating evidence that surgery with gastrointestinal manipulations may result in T2DM remission (metabolic surgery). The major mechanisms mediating the weight loss-independent effects of bariatric surgery comprise effects on tissue-specific insulin sensitivity, β-cell function and incretin responses, changes in bile acid composition and flow, modifications of gut microbiota, intestinal glucose metabolism and increased brown adipose tissue metabolic activity. Shorter T2DM duration, better preoperative glycemic control and profound weight loss, have been associated with higher rates of T2DM remission and lower risk of relapse. In the short and medium term, a significant amount of weight is lost, T2DM may completely regress, and cardiometabolic risk factors are dramatically improved. In the long term, metabolic surgery may achieve durable weight loss, prevent T2DM and cancer, improve overall glycemic control while leading to significant rates of T2DM remission, and reduce total and cause-specific mortality. The gradient of efficacy for weight loss and T2DM remission comparing the four established surgical procedures is biliopancreatic diversion >Roux-en-Y gastric bypass >sleeve gastrectomy >laparoscopic adjustable gastric banding. According to recently released guidelines, bariatric surgery should be recommended in diabetic patients with class III obesity, regardless of their level of glycemic control, and patients with class II obesity with inadequately controlled T2DM despite lifestyle and optimal medical therapy. Surgery should also be considered in patients with class I obesity and inadequately controlled hyperglycemia despite optimal medical treatment. |
X Demographics
The data shown below were collected from the profiles of 65 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 12 | 18% |
| United Kingdom | 7 | 11% |
| Mexico | 4 | 6% |
| Spain | 4 | 6% |
| Ireland | 3 | 5% |
| Chile | 3 | 5% |
| Colombia | 3 | 5% |
| El Salvador | 1 | 2% |
| Singapore | 1 | 2% |
| Other | 7 | 11% |
| Unknown | 20 | 31% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 38 | 58% |
| Practitioners (doctors, other healthcare professionals) | 20 | 31% |
| Scientists | 5 | 8% |
| Science communicators (journalists, bloggers, editors) | 2 | 3% |
Mendeley readers
The data shown below were compiled from readership statistics for 332 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 332 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Bachelor | 52 | 16% |
| Student > Master | 43 | 13% |
| Researcher | 38 | 11% |
| Student > Ph. D. Student | 24 | 7% |
| Student > Doctoral Student | 19 | 6% |
| Other | 51 | 15% |
| Unknown | 105 | 32% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 104 | 31% |
| Biochemistry, Genetics and Molecular Biology | 30 | 9% |
| Nursing and Health Professions | 15 | 5% |
| Agricultural and Biological Sciences | 13 | 4% |
| Pharmacology, Toxicology and Pharmaceutical Science | 13 | 4% |
| Other | 34 | 10% |
| Unknown | 123 | 37% |
Attention Score in Context
This research output has an Altmetric Attention Score of 61. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 15 July 2023.
All research outputs
#714,989
of 25,824,818 outputs
Outputs from BMC Endocrine Disorders
#22
of 881 outputs
Outputs of similar age
#14,687
of 328,731 outputs
Outputs of similar age from BMC Endocrine Disorders
#1
of 14 outputs
Altmetric has tracked 25,824,818 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 97th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 881 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.6. This one has done particularly well, scoring higher than 97% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 328,731 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 95% of its contemporaries.
We're also able to compare this research output to 14 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 92% of its contemporaries.